» Articles » PMID: 26498914

MicroRNA Expression and Its Implications for Diagnosis and Therapy of Tongue Squamous Cell Carcinoma

Overview
Journal J Cell Mol Med
Date 2015 Oct 27
PMID 26498914
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Tongue squamous cell carcinoma (TSCC) is the most common type of oral squamous cell carcinomas and is well known for its high rate of lymph nodal metastasis. Despite the identification of many molecular mechanisms in TSCC, the number of deaths associated with TSCC increased during the past 5 years. MicroRNAs (miRNAs) are a family of small non-coding RNA molecules, which regulate gene expression by either translational inhibition or mRNA degradation. miRNAs have been proven to be key regulators of various biological and pathological processes including cell proliferation, development and tumourigenesis. Increasing evidence has demonstrated that the deregulated miRNAs are implicated in the diagnosis and treatment of TSCC. In this review, we summarized the expressions and roles of miRNAs in TSCC and comment on the potential roles of miRNAs in diagnosis, prognosis and treatment of this malignancy.

Citing Articles

Current research trends and hotspots of boron neutron capture therapy: a bibliometric and visualization analysis.

Cong Y, Abulimiti M, Matsumoto Y, Jin J Front Oncol. 2024; 14:1507157.

PMID: 39726703 PMC: 11669655. DOI: 10.3389/fonc.2024.1507157.


MicroRNA expression as a prognostic biomarker of tongue squamous cell carcinoma (TSCC): a systematic review and meta-analysis.

Sun Y, Li Y, Zhou W, Liu Z BMC Oral Health. 2024; 24(1):406.

PMID: 38556858 PMC: 10981818. DOI: 10.1186/s12903-024-04182-0.


Identification of Family with Sequence Similarity 110 Member C (FAM110C) as a Candidate Diagnostic and Prognostic Biomarker for Glioma.

Ren D, Zhuang X, Lv Y, Zhang Y, Xu J, Gao F Iran J Public Health. 2023; 52(10):2117-2127.

PMID: 37899918 PMC: 10612548. DOI: 10.18502/ijph.v52i10.13850.


Early to sustained impacts of lethal radiation on circulating miRNAs in a minipig model.

Chakraborty N, Holmes-Hampton G, Gautam A, Kumar R, Hritzo B, Legesse B Sci Rep. 2023; 13(1):18496.

PMID: 37898651 PMC: 10613244. DOI: 10.1038/s41598-023-45250-9.


CDK1 Promotes Epithelial-Mesenchymal Transition and Migration of Head and Neck Squamous Carcinoma Cells by Repressing ∆Np63α-Mediated Transcriptional Regulation.

Chen H, Hu K, Xie Y, Qi Y, Li W, He Y Int J Mol Sci. 2022; 23(13).

PMID: 35806389 PMC: 9266818. DOI: 10.3390/ijms23137385.


References
1.
Zhou J, Song S, Cen J, Zhu D, Li D, Zhang Z . MicroRNA-375 is downregulated in pancreatic cancer and inhibits cell proliferation in vitro. Oncol Res. 2013; 20(5-6):197-203. DOI: 10.3727/096504013x13589503482734. View

2.
Manikandan M, Deva Magendhra Rao A, Rajkumar K, Rajaraman R, Munirajan A . Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics. J Oral Pathol Med. 2014; 44(10):792-800. DOI: 10.1111/jop.12300. View

3.
Xu J, Yang L, Ma C, Huang Y, Zhu G, Chen Q . MiR-25-3p attenuates the proliferation of tongue squamous cell carcinoma cell line Tca8113. Asian Pac J Trop Med. 2013; 6(9):743-7. DOI: 10.1016/S1995-7645(13)60130-3. View

4.
Li Z, Yu X, Shen J, Jiang Y . MicroRNA dysregulation in uveal melanoma: a new player enters the game. Oncotarget. 2015; 6(7):4562-8. PMC: 4467099. DOI: 10.18632/oncotarget.2923. View

5.
Yu Z, Zhong L, Ji T, Zhang P, Chen W, Zhang C . MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines. Oral Oncol. 2010; 46(4):317-22. DOI: 10.1016/j.oraloncology.2010.02.002. View